SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-22-002529
Filing Date
2022-04-11
Accepted
2022-04-11 17:04:49
Documents
14
Period of Report
2022-04-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_041122.htm   iXBRL 8-K 29106
2 EXHIBIT 10.1 exh_101.htm EX-10.1 99297
3 EXHIBIT 99.1 exh_991.htm EX-99.1 13819
  Complete submission text file 0001171843-22-002529.txt   350574

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE apto-20220408.xsd EX-101.SCH 3009
5 XBRL LABEL FILE apto-20220408_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE apto-20220408_pre.xml EX-101.PRE 22579
8 EXTRACTED XBRL INSTANCE DOCUMENT f8k_041122_htm.xml XML 3706
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 22820287
SIC: 2836 Biological Products, (No Diagnostic Substances)